Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Coyle

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Journal of Medical Genetics|June 30, 2000
Identification of two different mutations in the PDS gene in an inbred family with Pendred syndromeP J Coucke, P Van Hauwe, L A Everett, et al.
Thrombosis and Haemostasis|May 25, 2013
Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohortDaniel J Hampshire, Adel M Abuzenadah, Ashley Cartwright, et al.
Chemistry of Materials : a Publication of the American Chemical Society|February 9, 2026
Effect of Annealing on Direct Recycled NMC CathodesJuliane I Preimesberger, Cyrus K Kirwa, Eva Allen, et al.
Pharmacotherapy|June 11, 2026
Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control StudyDavid K Carroll, Eric A Woodcock, Andrew King, et al.
Journal of Medicinal Chemistry|August 20, 2010
Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiencyChristopher W Murray, Maria G Carr, Owen Callaghan, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Fragment-based discovery of type I inhibitors of maternal embryonic leucine zipper kinaseChristopher N Johnson, Valerio Berdini, Lijs Beke, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Fragment-Based Discovery of Potent and Selective DDR1/2 InhibitorsChristopher W Murray, Valerio Berdini, Ildiko M Buck, et al.
Journal of Medicinal Chemistry|December 10, 2016
Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>)Alison J-A Woolford, Philip J Day, Véronique Bénéton, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper KinaseChristopher N Johnson, Christophe Adelinet, Valerio Berdini, et al.
Genetic Epidemiology|May 27, 2005
Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmaticsKeyan Salari, Shweta Choudhry, Hua Tang, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Journal of Medical Genetics|June 30, 2000
Identification of two different mutations in the PDS gene in an inbred family with Pendred syndromeP J Coucke, P Van Hauwe, L A Everett, et al.
Thrombosis and Haemostasis|May 25, 2013
Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohortDaniel J Hampshire, Adel M Abuzenadah, Ashley Cartwright, et al.
Chemistry of Materials : a Publication of the American Chemical Society|February 9, 2026
Effect of Annealing on Direct Recycled NMC CathodesJuliane I Preimesberger, Cyrus K Kirwa, Eva Allen, et al.
Pharmacotherapy|June 11, 2026
Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control StudyDavid K Carroll, Eric A Woodcock, Andrew King, et al.
Journal of Medicinal Chemistry|August 20, 2010
Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiencyChristopher W Murray, Maria G Carr, Owen Callaghan, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Fragment-based discovery of type I inhibitors of maternal embryonic leucine zipper kinaseChristopher N Johnson, Valerio Berdini, Lijs Beke, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Fragment-Based Discovery of Potent and Selective DDR1/2 InhibitorsChristopher W Murray, Valerio Berdini, Ildiko M Buck, et al.
Journal of Medicinal Chemistry|December 10, 2016
Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>)Alison J-A Woolford, Philip J Day, Véronique Bénéton, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper KinaseChristopher N Johnson, Christophe Adelinet, Valerio Berdini, et al.
Genetic Epidemiology|May 27, 2005
Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmaticsKeyan Salari, Shweta Choudhry, Hua Tang, et al.
Pageof 16